Evidence map›Paper›PMID 32410021›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2020

Analysis of Lifespan in C. elegans: Low- and High-Throughput Approaches.

Adam B Cornwell, Andrew V Samuelson

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phenotypic Screening inPharmaceuticals (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adam B CornwellDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Andrew V SamuelsonDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA. Andrew_Samuelson@URMC.Rochester.edu.

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Transcriptional control of proteostasis and agingRF1AG062593 · NIA · UNIVERSITY OF ROCHESTER · PI SAMUELSON, ANDREW VAUGHN · 2019 to 2022
$2.2M
Mechanisms of the Mlx and Max Transcriptional Network in AgingR01AG043421 · NIA · UNIVERSITY OF ROCHESTER · PI SAMUELSON, ANDREW VAUGHN · 2014 to 2018
$1.6M
NIA NIH HHS R01 AG043421NIA NIH HHS RF1 AG062593NIH HHS P40 OD010440
6 · The paper itself

Abstract

Lifespan is the most straightforward surrogate measure of aging, as it is easily quantifiable. A common approach to measure Caenorhabditis elegans lifespan is to follow a population of animals over time and score viability based on movement. We previously developed an alternative approach, called the Replica Set method, to quantitatively measure lifespan of C. elegans in a high-throughput manner. The replica set method allows a single investigator to screen more treatments or conditions in the same amount of time without loss of data quality. The method requires common equipment found in most laboratories working with C. elegans and is thus simple to adopt. Unlike traditional approaches, the Replica Set method centers on assaying independent samples of a population at each observation point, rather than a single sample over time as with "traditional" longitudinal methods. The protocols provided here describe both the traditional experimental approach and the Replica Set method, as well as practical considerations for each.

Indexed as

AgingAnimalsBiological AssayCaenorhabditis elegansLongevityAgingC. elegansHigh-throughputKaplan–MeierLifespanLogistic regressionStatistical analysis of quantitative phenotypesSurvival analysis

Identifiers

PMID32410021
PMCPMC9113156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.